Sanofi Vaccines Canada Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 1755 Steeles Ave W, North York, M2R 3T4, Canada (CAN)
- Operations here
- manufacture
- FDA identifiers
- FEI 3002888623 · DUNS 208206623
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIVaccines and Allergenic Products2025-03-18
- VAIVaccines and Allergenic Products2022-10-28
- VAIVaccines and Allergenic Products2019-05-24
- VAIVaccines and Allergenic Products2013-09-20
- OAIVaccines and Allergenic Products2012-04-25
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- Tuberculin Purified Protein DerivativeSanofi Vaccines US Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.